ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
10 hedge funds and large institutions have $29.5M invested in Anebulo Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.01% less ownership
Funds ownership: 17.96% → 17.95% (-0.01%)
Holders
10
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$60.9K | |
| 2 | +$10.8K | |
| 3 | +$5.18K | |
| 4 |
Morgan Stanley
New York
|
+$7 |
Top Sellers
| 1 | -$53.7K | |
| 2 | -$37.1K | |
| 3 | -$3K | |
| 4 |
BlackRock
New York
|
-$2.46K |